Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

434
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
434
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

3.7K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.7K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

577
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
577
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

801
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
801
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

726
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
726
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

5.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Status and challenges after one hundred years with von Willebrand disease.

Danish medical journal·2026
Same author

Endothelial cell dysfunction and postoperative complications in patients with severe mesenteric traction syndrome: A prospective cohort study.

Microvascular research·2026
Same author

Structural variants in human congenital heart disease disrupt distal genomic regulatory contacts of developmental genes.

bioRxiv : the preprint server for biology·2026
Same author

A gut microbiome-kidney-heart axis predictive of future cardiovascular diseases.

Nature communications·2026
Same author

Menstrual cycle phase and hormonal contraceptive use influence circulating proforms of atrial natriuretic peptide, adrenomedullin, and the vasopressin proxy copeptin in healthy women.

Peptides·2026
Same author

Plasma growth differentiation factor-15 is associated with cardiovascular events in patients hospitalized for acute exacerbation of COPD.

Scientific reports·2026
Same journal

Inclusive cardiovascular care for sexual and gender minority populations.

Nature reviews. Cardiology·2026
Same journal

Modular cardiac microtissues for interrogating cell-type contributions.

Nature reviews. Cardiology·2026
Same journal

Sleep and exercise can limit clonal haematopoiesis clone expansion and reduce associated atherosclerosis.

Nature reviews. Cardiology·2026
Same journal

Epigenetic regulation in atherosclerosis and its therapeutic potential.

Nature reviews. Cardiology·2026
Same journal

Coronary artery calcium on chest CT scans: from incidental finding to mandatory reporting.

Nature reviews. Cardiology·2026
Same journal

Mitochondrial cardiomyopathy: bridging molecular mechanisms and clinical frontiers.

Nature reviews. Cardiology·2026
See all related articles

Related Experiment Video

Updated: Dec 20, 2025

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

11.3K

Cardiac natriuretic peptides.

Jens P Goetze1, Benoit G Bruneau2,3, Hugo R Ramos4,5

  • 1Department of Clinical Biochemistry, Rigshospitalet University Hospital, Copenhagen, Denmark.

Nature Reviews. Cardiology
|May 24, 2020
PubMed
Summary
This summary is machine-generated.

The heart

More Related Videos

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.2K
Time-Resolved In Vivo Measurement of Neuropeptide Dynamics by Capacitive Immunoprobe in Porcine Heart
08:20

Time-Resolved In Vivo Measurement of Neuropeptide Dynamics by Capacitive Immunoprobe in Porcine Heart

Published on: May 19, 2022

2.3K

Related Experiment Videos

Last Updated: Dec 20, 2025

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

11.3K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.2K
Time-Resolved In Vivo Measurement of Neuropeptide Dynamics by Capacitive Immunoprobe in Porcine Heart
08:20

Time-Resolved In Vivo Measurement of Neuropeptide Dynamics by Capacitive Immunoprobe in Porcine Heart

Published on: May 19, 2022

2.3K

Area of Science:

  • Cardiovascular Endocrinology
  • Molecular Cardiology
  • Biomarker Discovery

Background:

  • Cardiomyocytes exhibit a mixed muscle-secretory phenotype.
  • The heart possesses an endocrine function, producing polypeptide hormones.

Purpose of the Study:

  • To investigate the endocrine function of the heart.
  • To explore the role of natriuretic peptides in cardiovascular physiology and disease.

Main Methods:

  • Investigated cardiomyocyte phenotype.
  • Studied gene regulation of atrial natriuretic factor (ANP).
  • Identified natriuretic peptides as ligands for guanylyl cyclase receptors.

Main Results:

  • Discovered cardiomyocytes produce atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP).
  • Established natriuretic peptides mediate effects via cGMP signaling.
  • Demonstrated ANP and BNP as diagnostic and prognostic biomarkers for heart disease.

Conclusions:

  • The heart has a significant endocrine role.
  • Natriuretic peptides are crucial in cardiovascular regulation and disease.
  • Pharmacological targeting of natriuretic peptides holds therapeutic potential for cardiovascular diseases.